Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.7.0.1
Income Taxes (Tables)
12 Months Ended
Jun. 30, 2017
Income Tax Disclosure [Abstract]  
Comprehensive Income (Loss) [Table Text Block]
The components of net loss consist of the following (in thousands):
 
 
 
For the Years Ended
June 30,
 
 
 
2017
 
2016
 
United States
 
$
(16,122)
 
$
(10,635)
 
Brazil
 
 
(17)
 
 
(22)
 
Total
 
$
(16,139)
 
$
(10,657)
 
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
The components of the provision (benefit) for income taxes consist of the following (in thousands):
 
 
 
For the Years Ended
June 30,
 
 
 
2017
 
2016
 
Current – Federal, state and foreign
 
$
-
 
$
-
 
Deferred – Federal
 
 
(5,178)
 
 
(260)
 
Deferred – State
 
 
(866)
 
 
(9)
 
Deferred – Foreign
 
 
(4)
 
 
(1)
 
Total
 
 
(6,048)
 
 
(270)
 
Change in valuation allowance
 
 
6,048
 
 
270
 
Income tax expense
 
$
-
 
$
-
 
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
The components of the Company’s deferred tax assets and liabilities are as follows (in thousands):
 
 
 
As of June 30,
 
 
 
2017
 
2016
 
Deferred tax assets (liabilities):
 
 
 
 
 
 
 
Net operating loss
 
$
17,827
 
$
17,172
 
Share-based compensation
 
 
3,072
 
 
726
 
Research and development tax credits
 
 
1,285
 
 
1,097
 
Suspended losses in iBio CDMO
 
 
2,762
 
 
255
 
Basis in iBio CDMO
 
 
538
 
 
145
 
Intangible assets
 
 
(267)
 
 
(219)
 
Vacation accrual and other
 
 
24
 
 
17
 
Valuation allowance
 
 
(25,241)
 
 
(19,193)
 
Total
 
$
-
 
$
-
 
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
A reconciliation of the statutory tax rate to the effective tax rate is as follows:
 
 
 
Years Ended
June 30,
 
 
 
2017
 
2016
 
Statutory federal income tax rate
 
 
34
%
 
34
%
State (net of federal benefit)
 
 
6
%
 
6
%
Research and development tax credit
 
 
1
%
 
1
%
Permanent differences
 
 
(5)
%
 
(7)
%
Reclassification of incentive stock options to non-qualifying
 
 
13
%
 
-
%
Expiration of stock options and warrants
 
 
-
%
 
(31)
%
Change in valuation allowance
 
 
(49)
%
 
(3)
%
Effective income tax rate
 
 
-
%
 
-
%